Chronic Kidney Disease Analysis

The National Kidney Foundation information is provided in a question and answer format with one or two sentence simple answers provided. The Merck Manual site utilizes headers with information ranging between one to three paragraphs. Links available on the National Kidney Foundation Website keep the reader on the site and frequently take them back to the donation page. The Website provides a section for “Professional” users, however, the majority of the area is again written for the general public. One area reviewed provides an “Education and Research” option that takes the professional reader to more technical writing sources contained within the National Kidney Foundation Website. The Merck Manual links allow the reader to visit other Websites for additional subject information. The National Kidney Foundation Website offers additional educational opportunities via Webinars and seminars. No such offerings were noted on the Merck Manual site.

Chronic kidney disease (CKD) is a worldwide problem that is currently three times higher for African Americans, Hispanics, Pacific Islanders, American Indians and seniors (The National Kidney Foundation, 2013). CKD occurs when the kidneys are damaged by a pathogen or injury and they can no longer adequately maintain proper levels of regulated chemicals in the bloodstream. There are many risk associated with CKD. According to the National Kidney Foundation, two of the major risks are Chronic Renal Failure (CRF) and Cardiovascular Disease. Currently twenty million American adults have CKD and millions of others are at increased risk. Age has no barrier on getting CKD. People with pre-existing health issues, and a part of certain population

Chronic kidney disease (CKD) is a common disorder and occurs in the elderly population. In younger patients, it

Underdiaxonsied and undertreated it is a major concern for the aging population of the United States. One of the first steps is educating the public on early detection techniques and risk factor for developing CKD. High blood pressure and diabetes is a major contributor in developing the disease and thus high risk factor groups should be identified early. This way the individuals can begin implementing lifestyle changes that can not only decrease the rate of kidney function decline but improve it as well. Management of the disease focus on the major complications. Anemia, dyslipidemia, CKD-MBD, nutrition and cardiovascular are the forefront of the disease management. Management with not only medications, but lifestyle changes creates a holistic care plan specialized to each individual patient. By treating not CKD but the individual patient, outcomes will improve. Implementing the health care team as a whole will unify the strengths in modern medicine and thus relieve a huge financial burden that chronic kidney disease yields at a national and local

In the United States, over 5 million patients have heart failure (HF) and approximately 20 million patients have chronic kidney disease (CKD). Both conditions are linked by multiple risk factors including obesity, hypertension, diabetes mellitus, tobacco abuse, and increasing age. The presence of HF increases the risk of CKD and vice versa. Nearly one third of all patients with HF and 70% of Medicare patients with HF have Stage III CKD or greater and approximately 50% of dialysis dependent end stage renal disease (ESRD) patients will develop HF.

Chronic Kidney Disease (CKD) is a disease that is described as a loss of kidney function gradually over time. As kidney function decreases, the waste collection in the body’s blood becomes high and makes the individual feel sick. This disease can lead to other complications in the body such as anemia, poor nutritional health, high blood pressure, and nerve damage. These complications will begin to progress and show as CKD progresses to advanced stages. Early detection of this disease is essential when it comes to treatment. If CKD is diagnosed early enough the disease progression can be slowed down and managed. This disease will eventually lead to failure of the kidneys

Figure 1: Cardiovascular disease mortality by age, race, and gender in the general population and in dialysis patients. Cardiovascular mortality is defined as death due to arrhythmias, cardiomyopathy, cardiac arrest, myocardial infarction, atherosclerotic heart disease, and pulmonary oedema. Data from the general population are from the National Centre for Health Statistics multiple cause of mortality files 1993. Data from dialysis patients include haemodialysis and peritoneal dialysis combined from USRDS 1994-1996. Reprinted with permission from Am J Kidney Dis 32[Suppl 3]: S115, 1998.

End Stage Renal Disease also known as stage 5 of Chronic Kidney Disease. When this development happens you either need Dialysis or a kidney transplant to stay alive. DaVita has more than 2,100 outpatient dialysis centers located around the country. Our Kidneys are located in our lower back and are bean shaped organs that is very important to help our body filtrate waste and excess fluid amongst a few other things. It is said that “1 in 10 adults have Kidney Disease”.

Kidney disease has become more prevalent over the years, one in nine Americans has chronic kidney disease, resulting in the need for a kidney transplant. Kidney failure is caused by variety of factors resulting in damage of the nephrons, which are the most important functioning unit of the kidneys. Kidney failure can be broken down into three groups: acute, chronic, end-stage. Once kidney failure is irreversible, dialysis or transplantation is the only method of survival. To avoid a kidney transplant, one needs to be aware of the pre-disposing factors, signs and symptoms, available treatments, and proper diet.

In the article “Facilitating Change in Medical -Surgical Units Through an Educational Program on Chronic Kidney Disease” by Mary Ann S. Isales, exhibits the concerns of insufficient knowledge regarding with chronic kidney disease among professional medical-surgical nurses. The sole purpose of this article is due to the fact that an experimental analysis by Barrantes discovered that chronic kidney disease has become an extensive health issue; as a result, patient’s mortality has increased by seven folds. Furthermore, another case has a correlation with chronic kidney disease as it unfolds that five percent of hospitalized patients in noncritical areas will result in developing this atrocious condition. In spite of the concerns of obtaining this

End Stage Renal Disease is the last stage of Chronic Kidney Disease (CKD) which is a “progressive, irreversible loss of kidney function” (Lewis et. al. 2017 pp.1075). The kidneys are the main organs of the urinary system. They have many functions but the main functions are to “regulate the volume and composition of extracellular fluid and excrete waste products from the body” and maintaining hemostasis (Lewis et. al. 2017 pp 1015). The microstructures of the kidney that are most involved with the function of the kidney are the nephrons. The nephrons are responsible for filtering the blood from toxins such as uremia, creatinine and hydrogen. Therefore, when the nephrons are compromised by uremia, the manifestations can spread systemically. The

In order to measure the progression of the disease, it is vital to integrate various tests such as urine protein tests, blood pressure, and Glomerular filtration rate. There is still no known cure for the end stage renal disease. In order to manage this condition, patients normally require kidney transplantation and aspects of dialysis with the aim of continued survival. Without these management measures, patients would suffer from the formation of toxin and fluid in the blood and the aspect of uraemia. This

Chronic kidney disease (CKD) is an irreversible condition that progresses causing kidney dysfunction and then to kidney failure. It is classified by a GFR of <60mL/min for longer than 3 months. There are five stages of CKD: Stage 1 has kidney damage but has a GFR ≥ 90. Stage 2 has mild damage and a GFR of 60-89. Stage 3 has moderate damage and a GFR of 30-59. Stage 4 has severe damage and a GFR of 15-29. Stage 5 is also known as end stage renal disease (ESRD), this is kidney failure with a GFR of ≤ 15 and theses patients are typically on dialysis or in need of an immediate transplant. The leading cause of CKD is diabetes. Hypertension is also a major cause. Since most DM patients have HTN,

Chronic Kidney Disease (CKD) is among the leading causes of mortality throughout the world, and its prevalence and the health care costs resulting from it are considerable and increasing. CKD commonly is silent and asymptomatic until its late stages. Accordingly, CKD is diagnosed prior to symptomatic stage of kidney failure, resulting in delays in proper interventions and the emergence of adverse consequences in the CKD patients

stages, symptoms and risk factors. It also examines the process of kidney transplantation to treat